Welcome to The Catalyst
Change isn't quick. Unless it's when you experience Intravascular Lithotripsy (IVL) for the first time. Stay apprised of our latest news and insights while discovering how a simple and intuitive tool can be The Catalyst to change the way you think about calcium modification.
In case you missed its live airing, tune into a great discussion from coronary IVL’s most knowledgeable operators about how they are treating severely calcified lesions, their tips and tricks using IVL in real world practice as well as their clinical experience with IVL.
Topics: Coronary Cases, Coronary Clinical Data, Shockwave C2
If an image is worth a thousand words, then we’d have to write a novel to capture all of the key takeaways from the 300 OCT images (i.e. pre-IVL, post-IVL & post-DES) that were taken from the 100 patients that participated in the Disrupt CAD III OCT sub-analysis. Thankfully, we ditched the novel and opted for an easy-to-digest infographic to capture the 10 most pertinent data points from the OCT study presented at TCT Connect. Happy viewing!
Topics: Coronary Cases, Coronary Clinical Data, Shockwave C2
Eccentric calcium has always been a ‘pain’…a real thorn in the interventionalists’ side. While current devices in eccentric calcium often expand the healthy, non-calcified side of the artery or fall subject to wire bias that prevents it from reaching the calcified side of the artery, coronary Intravascular Lithotripsy (IVL) offers a new alternative that can modify both concentric and eccentric calcium equally as well. Don’t be satisfied with less than ideal stent expansion in eccentric calcium, instead learn how Dr. Margaret McEntegart has used IVL to modify eccentric calcium in the left main and hear Profs. Holger Nef & Carlo Di Mario share their recent publications and clinical data comparing IVL outcomes in eccentric and concentric calcified lesions.
Assessment and Management of Calcified Coronary Lesions, Part 1/5
Live in a Box: Left Main Bifurcation Lesion with Eccentric Calcium, Part 2/5
CAD I/II Analysis: Eccentric Vs. Concentric Lesions, Part 3/5
Lithotripsy in Eccentric and Concentric Coronary Calcifications, Part 4/5
Discussion and Conclusion, Part 5/5
Topics: Coronary Cases, Coronary Clinical Data, Shockwave C2, CAD Applications - Eccentric Lesions
Dr. Sandeep Basavarajaiah, consultant cardiologist at Heartlands Hospital in Birmingham, UK, and other leading UK and Italian cardiologists published their initial real-world experience with Intravascular Lithotripsy (IVL) in a real-world population, in Catheter Cardiovasc Interv: “Intravascular lithotripsy in calcified-coronary lesions: A real-world observational, European multicenter study”.
Topics: Coronary IVL, Coronary Clinical Data, Shockwave C2
At TCT Connect, investigators presented the 30-day primary endpoint analysis of the Disrupt CAD III study, the largest and most rigorous coronary IVL study to date.
Topics: Coronary IVL, DISRUPT CAD, Coronary Cases, Coronary Clinical Data
Perspective on IVL-Induced Ventricular Capture from Keith D. Dawkins, M.D., Chief Medical Officer, Shockwave Medical, Inc.:
Topics: Coronary IVL, Coronary Clinical Data, Clinical Corner with Dr. Keith Dawkins
Following its presentation as a late-breaking clinical at TCT Connect and simultaneous publication in the Journal of the American College of Cardiology (JACC) we sat down with Dr. Jonathan Hill, Consultant Cardiologist at the Royal Brompton Hospital in London, to get his perspective on the results, how they build on CAD I & II outcomes, and where they fit into clinician’s daily decision-making process when treating calcified lesions. We hope you enjoy his perspective.
Topics: Coronary IVL, DISRUPT CAD, Coronary Clinical Data, Shockwave C2, Coronary Conferences
Last month the DISRUPT CAD III investigators, led by co-PIs Drs. Dean Kereiakes and Jonathan Hill, published in the American Heart Journal the trial design and rationale paper titled, “Evaluation of safety and efficacy of coronary intravascular lithotripsy for treatment of severely calcified coronary stenoses: Design and rationale for the Disrupt CAD III trial.”
Topics: Coronary IVL, DISRUPT CAD, Coronary Clinical Data
Prof. Carlo Di Mario, Director of Structural Interventional Cardiology at the Careggi University Hospital in Florence, Italy, and other cardiologists in Florence recently published their initial real-world experience when using intravascular imaging while treating coronary lesions with Intravascular Lithotripsy (IVL).
Topics: Coronary IVL, Coronary Clinical Data, Shockwave C2, CAD Applications - Eccentric Lesions
In case you weren’t able to make it to EuroPCR’s e-Course last week, you missed a great discussion among some of coronary IVL’s most knowledgeable operators about how they’re using the technology in the real-world setting. Lucky for you, we’ve included the sponsored roundtable discussion below featuring Drs. Benjamin Honton (FR), Javier Escaned (ES) and Michael Lee (HK). We hope you enjoy hearing their perspectives from across Europe and Asia.
Topics: Coronary IVL, Coronary Cases, Coronary Clinical Data, Shockwave C2, Coronary Conferences, CAD Applications - Eccentric Lesions
But, right now we're in the early phases of the R&D program. In the meantime, don't miss the IVL application that heart teams are embracing already — maintaining transfemoral TAVR access through heavily calcified iliacs by using IVL.
